These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 28233255

  • 1. MRI for Quantification of Liver and Cardiac Iron in Thalassemia Major Patients: Pilot Study in Indian Population.
    Mandal S, Sodhi KS, Bansal D, Sinha A, Bhatia A, Trehan A, Khandelwal N.
    Indian J Pediatr; 2017 Apr; 84(4):276-282. PubMed ID: 28233255
    [Abstract] [Full Text] [Related]

  • 2. Correlation between liver iron concentration determined by magnetic resonance imaging and serum ferritin in adolescents with thalassaemia disease.
    Chuansumrit A, Laothamathat J, Sirachainan N, Sungkarat W, Wongwerawattanakoon P, Kumkrua P.
    Paediatr Int Child Health; 2016 Aug; 36(3):203-8. PubMed ID: 27595699
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.
    Wahidiyat PA, Liauw F, Sekarsari D, Putriasih SA, Berdoukas V, Pennell DJ.
    Hematology; 2017 Sep; 22(8):501-507. PubMed ID: 28218005
    [Abstract] [Full Text] [Related]

  • 4. [Liver and heart iron deposition status in patients with β thalassemia major: a multicenter study].
    Li C, Liu S, Wang Y, Wen F, Gao H, Chen G, Li C, Wu X, Fang J, Hao W, Liu R, Zhang X, Chu CW, Au W.
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):90-3. PubMed ID: 24739717
    [Abstract] [Full Text] [Related]

  • 5. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
    Wu X, Jing Y, Pei F, Chen J, Feng X, He Y, Zhang Y, Li C.
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
    [Abstract] [Full Text] [Related]

  • 6. Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.
    Ouederni M, Ben Khaled M, Mellouli F, Ben Fraj E, Dhouib N, Yakoub IB, Abbes S, Mnif N, Bejaoui M.
    Ann Hematol; 2017 Jan; 96(1):133-139. PubMed ID: 27730342
    [Abstract] [Full Text] [Related]

  • 7. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A, Yazman D, Economides C, Eracleous E, Kontoghiorghes GJ.
    Hemoglobin; 2009 Jan; 33(5):312-22. PubMed ID: 19814677
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
    Pipaliya N, Solanke D, Parikh P, Ingle M, Sharma R, Sharma S, Sawant P.
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
    [Abstract] [Full Text] [Related]

  • 9. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.
    Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S, Dimitriadis AS, Athanassiou-Metaxa M.
    J Pediatr Hematol Oncol; 2006 May; 28(5):311-5. PubMed ID: 16772883
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia.
    Wahidiyat PA, Iskandar SD, Sekarsari D.
    Acta Med Indones; 2018 Jul; 50(3):230-236. PubMed ID: 30333273
    [Abstract] [Full Text] [Related]

  • 11. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
    Jarisch A, Salzmann-Manrique E, Cario H, Grosse R, Soerensen J, Fischer R, Schulz A, Hammerstingl R, Wunderlich A, Bader P.
    Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
    [Abstract] [Full Text] [Related]

  • 12. The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients.
    Chaosuwannakit N, Makarawate P, Wanitpongpun C.
    Tomography; 2021 Apr 18; 7(2):130-138. PubMed ID: 33919601
    [Abstract] [Full Text] [Related]

  • 13. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM, Liem RI, Rigsby CK, Labotka RJ, DeFreitas RA, Thompson AA.
    Br J Haematol; 2016 Nov 18; 175(4):705-713. PubMed ID: 27507431
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of cardiac iron load by cardiac magnetic resonance in thalassemia.
    Merchant R, Joshi A, Ahmed J, Krishnan P, Jankharia B.
    Indian Pediatr; 2011 Sep 18; 48(9):697-701. PubMed ID: 21169646
    [Abstract] [Full Text] [Related]

  • 15. Correlation of serum ferritin levels with hepatic MRI T2 and liver iron concentration in nontransfusion beta-thalassemia intermediate patients: A contemporary issue.
    Karimi M, Amirmoezi F, Haghpanah S, Ostad S, Lotfi M, Sefidbakht S, Rezaian S.
    Pediatr Hematol Oncol; 2017 Aug 18; 34(5):292-297. PubMed ID: 29190176
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of heart and liver iron deposition status in patients with β- thalassemia intermedia and major with MRI T2* technique].
    Li CG, Liu SX, Mai HR, Wang Y, Wen FQ, Liu RY, Zhang XH, Chu WC, Au WY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Feb 18; 14(2):110-3. PubMed ID: 22357467
    [Abstract] [Full Text] [Related]

  • 17. A practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac T2*.
    Ha SY, Mok AS, Chu WC, Raskalkar DD, Cheuk DK, Chiang AK, Ho MH, Chan GC.
    Hemoglobin; 2009 Feb 18; 33(5):323-31. PubMed ID: 19814678
    [Abstract] [Full Text] [Related]

  • 18. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*.
    Kolnagou A, Natsiopoulos K, Kleanthous M, Ioannou A, Kontoghiorghes GJ.
    Toxicol Mech Methods; 2013 Jan 18; 23(1):48-56. PubMed ID: 22943064
    [Abstract] [Full Text] [Related]

  • 19. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, Loutradi A, Loukopoulos D.
    Br J Haematol; 2004 Sep 18; 126(5):736-42. PubMed ID: 15327528
    [Abstract] [Full Text] [Related]

  • 20. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V, Rigoli L, Lacquaniti A, Salpietro V, Piraino B, Amorini M, Salpietro C, Arrigo T.
    Eur J Haematol; 2015 May 18; 94(5):404-12. PubMed ID: 25200112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.